Abstract This 2022 European Atherosclerosis Society lipoprotein (a)[Lp (a)] consensus
statement updates evidence for the role of Lp (a) in atherosclerotic cardiovascular disease …

Objective This guideline will provide the practicing endocrinologist with an approach to the
assessment and treatment of dyslipidemia in patients with endocrine diseases, with the …

Over the last 10 years, there have been advances on several aspects of lipoprotein (a)
which are reviewed in the present article. Since the standard immunoassays for measuring …

Background: Reference ranges for serum thyrotropin (TSH), free thyroxine (fT4), and free
triiodothyronine (fT3) established without considering age-and sex-based differences are …

An elevated level of lipoprotein (a)[Lp (a)] is a genetically regulated, independent, causal
risk factor for cardiovascular disease. However, the extensive variability in Lp (a) levels …

Background Thyroid disorders, both overt and subclinical, are highly prevalent conditions in
the general population. Although a clear relationship between overt thyroid dysfunctions and …

For specific recognition and sensitive detection of triglycerides (TGs), an optical fiber sensor
(OFS) based on an enhanced core diameter mismatch was proposed. The sensitivity of the …

Purpose Hypothyroidism is a relatively common endocrine disorder and is well documented
to be associated with lipid abnormalities. Methods A narrative review was conducted of …

Thyroid function has a close link with inflammation. However, it is still unknown whether the
dietary inflammatory potential is associated with thyroid function. We aimed to assess the …

Aims In view of the consolidating evidence on the causal role of Lp (a) in cardiovascular
disease, the Italian Society for the Study of Atherosclerosis (SISA) has assembled a …